Search This Blog

Friday, September 28, 2018

Insmed shares halted pending news


Nasdaq has suspended trading in Insmed (NASDAQ:INSM) pending the release of news, a near certainty that it is related to the pending FDA approval for ALIS for nontuberculous mycobacteria (NTM) lung disease.
Posted by at

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.

Subscribe to: Post Comments (Atom)